[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352505-105":59,"doc-detail-352505-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","rb1-i680t-mutation-potentiates-tumor-growth-and-chemotherapy-sensitivity-in-non-small-cell-lung-cancer-via-derepressing-e2f1-transcription","RB1-I680T mutation potentiates tumor growth and chemotherapy sensitivity in non-small cell lung cancer via derepressing E2F1 transcription","","RB1 is a tumor suppressor that limits malignant cancer progression, but mutations can promote tumorigenesis by impairing its function. This study characterizes a rare, previously unreported RB1 missense variant in non-small cell lung cancer (NSCLC): RB1-I680T, where the 680th residue isoleucine is replaced by threonine. Functional tests assess how the mutation alters tumor growth and chemotherapy response, and mechanistic work links RB1–E2F1 transcriptional regulation to NSCLC chemosensitivity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rb1-i680t-mutation-potentiates-tumor-growth-and-chemotherapy-sensitivity-in-non-small-cell-lung-cancer-via-derepressing-e2f1-transcription/352505/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rb1-i680t-mutation-potentiates-tumor-growth-and-chemotherapy-sensitivity-in-non-small-cell-lung-cancer-via-derepressing-e2f1-transcription/352505.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What RB1 mutation was investigated in NSCLC, and why is it significant?","Question",{"text":112,"@type":113},"The study investigated a rare RB1 missense mutation, RB1-I680T, where the 680th residue isoleucine is replaced by threonine. It addresses the unclear biological significance of specific rare RB1 variants in NSCLC.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers model the RB1-I680T mutation in cells and animals?",{"text":117,"@type":113},"They used CRISPR-Cas9 to knock out endogenous RB1 in NSCLC cells, then introduced either wild-type RB1 or RB1-I680T using lentiviral constructs. Resulting phenotypes were evaluated with in vitro and in vivo experiments.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings regarding tumor growth and chemotherapy response?",{"text":121,"@type":113},"RB1-I680T increased tumor growth and potentiated chemotherapy-induced tumor regression compared with the RB1-WT control. Mechanistically, it weakened RB1 inhibition of E2F1 transcriptional activity and supported enhanced proliferation and chemosensitivity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352505,1790497389,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Zhu et al. Cell Communication and Signaling (2026) 24:147  \n[https://doi.org/10.1186/s12964-026-02695-5](https://doi.org/10.1186/s12964-026-02695-5)  \nCell Communication and Signaling  \nRESEARCH Open Access  \nRB1-I680T mutation potentiates tumor  growth and chemotherapy sensitivity in nonsmall cell lung cancer via derepressing E2F1 transcription  \nYilin Zhu1†, Fengyuan Gao1†, Yu Liu1,2†, Jinfu Wang1, Fanrong Liu1,3, Biao Wang1, Boxuan Wu1, Yue Wang1, Yifan Zhang4, Zhongxian Tian1,5,6, Ning Mu5,6, Xianglin Zhang1,5,6, Xiaogang Zhao1,5,6, Yunpeng Zhao1,5,6* and Peichao Li1,5,6*  \nAbstract  \nBackground Retinoblastoma Transcriptional Corepressor 1 (RB1) is a critical tumor suppressor restricting the malignant progression of cancer cells. Emerging evidence indicates that RB1 mutations typically promote tumorigenesis through loss of its tumor-suppressive functions. Yet, the biological significance of mutated RB1, specifically certain rare variants, in non-small cell lung cancer (NSCLC) remains elusive. Here, we first reported a rare and previously uncharacterized missense mutation in RB1, the 680th residue isoleucine replaced by threonine (RB1-I680T), in NSCLC.  \nMethods To investigate the functional and mechanistic consequences ofthe RB1-I680T mutation in NSCLC, we first used CRISPR-Cas9 to knock out endogenous RB1 in NSCLC cells. Then, we generated cell models harboring the RB1-I680T mutation by infecting these knockout cells with lentivirus carrying either wild-type RB1 (RB1-WT) or RB1-I680T expression constructs. The biological phenotypes mediated by RB1-I680T were investigated using in vitro and in vivo experiments. The exploration of the molecular mechanism was performed primarily through co-immunoprecipitation, immunofluorescence, dual-luciferase reporter assays, western blot analysis, and protein docking and dynamics simulation.  \nResults Our study demonstrated that the I680T mutation caused faster tumor growth and potentiated chemotherapy-induced tumor regression compared to RB1-WT control. Mechanistic studies illustrated that the I680T mutation in RB1 disrupted its inhibition of E2F1 transcriptional activity by weakening the physical interaction between  \n†Yilin Zhu, Fengyuan Gao andYu Liu contributed equally to this work.  \n*Correspondence:  \nYunpeng Zhao [zhaoyunpengsddx@sdu.edu.cn](zhaoyunpengsddx@sdu.edu.cn)[ ](zhaoyunpengsddx@sdu.edu.cn)Peichao Li[lipeichao@email.sdu.edu.cn](lipeichao@email.sdu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nZhu et al. Cell Communication and Signaling (2026) 24:147 Page 2 of 18  \nRB1 and E2F1 in a manner dependent on conformational flexibility of RB1 pocket B domain, which is essential for sustaining the enhanced proliferation and chemosensitivity in NSCLC cells.  \nConclusion Our findings elucidate that the I680T mutation-indu","cbCairx8dX7EeC5c","https://ap.wps.com/l/cbCairx8dX7EeC5c","pdf",15758402,18,"English","# Abstract\n# Background\n# Methods\n## Functional investigation\n## Mechanistic investigation\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What RB1 mutation was investigated in NSCLC, and why is it significant?\",\"answer\":\"The study investigated a rare RB1 missense mutation, RB1-I680T, where the 680th residue isoleucine is replaced by threonine. It addresses the unclear biological significance of specific rare RB1 variants in NSCLC.\"},{\"question\":\"How did the researchers model the RB1-I680T mutation in cells and animals?\",\"answer\":\"They used CRISPR-Cas9 to knock out endogenous RB1 in NSCLC cells, then introduced either wild-type RB1 or RB1-I680T using lentiviral constructs. Resulting phenotypes were evaluated with in vitro and in vivo experiments.\"},{\"question\":\"What were the key findings regarding tumor growth and chemotherapy response?\",\"answer\":\"RB1-I680T increased tumor growth and potentiated chemotherapy-induced tumor regression compared with the RB1-WT control. Mechanistically, it weakened RB1 inhibition of E2F1 transcriptional activity and supported enhanced proliferation and chemosensitivity.\"}]","RB1-I680T mutation potentiates tumor growth and chemotherapy sensitivity in non-small cell lung cancer via derepressing E2F1 transcription | PDF",1790100017,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9944b8845f783de7459cf292412ea00e.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/709573053d47336e4e7d6ed78e07402c.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/489fd0e09df460b6821bbae452e32f21.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d67eb1ae71f49f52e0bd5e18c34b5dcf.webp",980,1306]